Mikrogen Diagnostics acquires Lophius Biosciences

12-Mar-2021 - Germany

The diagnostic company Mikrogen GmbH from Neuried is acquiring Lophius Biosciences GmbH from BioPark Regensburg to enter the future market of T-cell based tests. Immunodiagnostics plays a huge role in the fields of transplantation as well as infectious diseases and autoimmune disease.

pixabay.com

Symbolic image

Lophius Biosciences GmbH founded from the University of Regensburg in 2002 has been acquired by Mikrogen Diagnostics. Since 1989 Mikrogen GmbH in Upper Bavarian Neuried has been producing antigens for clinical diagnostics. The global supplier of system solutions for medical laboratory diagnostics offers a multitude of serological and molecular diagnostic systems. The specialty lies in the direct (PCR) and indirect detection of bacterial, viral and parasitic infections as well as of autoimmune disease and cancer. The combination of know-how in diagnostics and automation by Mikrogen with the technology from Lophius for pathogen-specific immunostimulation will facilitate novel diagnostic solutions for infectious diseases and complete the Mikrogen portfolio. Mikrogen will expand operations by taking over the entire Lophius team and the Lophius laboratories at BioPark Regensburg. In the future in-vitro diagnosis kits developed by Lophius will be marketed by Mikrogen.

“We are looking forward to be able to welcome our new colleagues from Lophius on board. We believe that leading both teams together and their complementary specialist knowledge will expedite the strength of our innovation in the development of new diagnostic solutions”, said Dr. Erwin Soutschek, CEO & Managing Director of Mikrogen GmbH.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Something is happening in the life science industry ...

This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures